|
Re: Don's discount
|
4
|
Resverlogix Corp.
|
Feb 05, 2018 03:17PM
|
|
Re: Don's discount
|
4
|
Resverlogix Corp.
|
Feb 04, 2018 06:10PM
|
|
Re: Don's Milestones/ Major Achievements at RVX
|
3
|
Resverlogix Corp.
|
Sep 02, 2022 07:58PM
|
|
Re: Don't miss your chance - anyone interested in applying?
|
4
|
Resverlogix Corp.
|
Jul 06, 2022 12:45PM
|
|
Re: Don't miss your chance - anyone interested in applying?
|
3
|
Resverlogix Corp.
|
Jul 07, 2022 02:32PM
|
|
Re: Don't See Us Listed but thought it might interest some
|
6
|
Resverlogix Corp.
|
Mar 10, 2021 11:57AM
|
|
Re: Dr Sweeney
|
4
|
Resverlogix Corp.
|
Jun 22, 2016 11:09AM
|
|
Re: Dr Sweeney
|
2
|
Resverlogix Corp.
|
Jun 22, 2016 11:34AM
|
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
4
|
Resverlogix Corp.
|
Aug 15, 2022 07:08PM
|
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
4
|
Resverlogix Corp.
|
Aug 15, 2022 09:40PM
|
|
Re: Drop in price
|
4
|
Resverlogix Corp.
|
Jul 09, 2021 11:03AM
|
|
Re: Dropping on the opening on the "pinks"
|
3
|
Resverlogix Corp.
|
Jul 29, 2015 12:39PM
|
|
Re: Drug Discovery Targeting BRD4
|
4
|
Resverlogix Corp.
|
Oct 04, 2017 05:09PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
4
|
Resverlogix Corp.
|
Mar 26, 2022 07:24AM
|
|
Re: DSMB 7th review??
|
4
|
Resverlogix Corp.
|
Jul 20, 2018 04:40PM
|
|
Re: early report imo
|
4
|
Resverlogix Corp.
|
Jul 03, 2022 12:09PM
|
|
Re: early report imo
|
5
|
Resverlogix Corp.
|
Jul 03, 2022 06:50PM
|
|
Re: EDITRe: i would love to hear,..
|
|
Resverlogix Corp.
|
Dec 06, 2019 10:55AM
|
|
Re: empagliflozin - a drug competitive to rvx-208???
|
3
|
Resverlogix Corp.
|
Nov 09, 2015 11:42AM
|
|
Re: Endocyte Valuation
|
2
|
Zenith Epigenetics
|
Oct 19, 2018 01:00PM
|
